Gates Foundation Commits US$50m To Ebola Response

The Bill & Melinda Gates Foundation Wednesday announced it will commit US$50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa.

According to a dispatch, the foundation will immediately release flexible funds to United Nations agencies and international organizations involved in the response to enable them and national governments to purchase badly needed supplies and scale up emergency operations in affected countries.

In addition, the foundation will work with public and private sector partners to accelerate the development of therapies, vaccines, and diagnostics that could be effective in treating patients and preventing further transmission of the disease.

“We are working urgently with our partners to identify the most effective ways to help them save lives now and stop transmission of this deadly disease,” said Sue Desmond-Hellmann, CEO of the Gates Foundation.

 “We also want to accelerate the development of treatments; vaccines and diagnostics that can help end this epidemic and prevent future outbreaks,” she said.

To date, the Gates Foundation has committed more than US$10 million to fight the Ebola outbreak, including US$5 million to the World Health Organization for emergency operations and R&D assessments.

Another US$5 million is for the U.S. Fund for UNICEF to support efforts in Liberia, Sierra Leone and Guinea to purchase essential medical supplies, coordinate response activities, and provide at-risk communities with life-saving health information.

An additional $2 million will also be committed immediately to the Centers for Disease Control and Prevention to support incident management, treatment, and health care system strengthening.

In August, Nigeria responded to the current crisis by opening an Emergency Operations Center (EOC) in Lagos, with support from the foundation and the Dangote Foundation.

As additional grants are made, the foundation will provide further details on its funding commitments to on-the-ground operations and to research and development for Ebola drugs, vaccines, and diagnostics, te dispatch added.

(Visited 37 times, 1 visits today)

Be the first to comment

Leave a Reply

Your email address will not be published.